Wegovy Weight Loss Injections Glasgow are available at Rightdose Clinic Glasgow. Wegovy® (semaglutide) is a prescription-only weekly injection used to support weight loss in eligible adults.
At Rightdose Clinic Glasgow, our pharmacist-led team provides comprehensive weight loss assessments, ongoing support and personalised treatment plans to help you achieve your goals safely and effectively.
✔ Pharmacist-led consultations
✔ Competitive pricing
✔ Ongoing support and monitoring
✔ Convenient Glasgow Southside location
✔ Same and next-day appointments available
Wegovy (semaglutide) is a prescription-only weekly injection used to support weight loss in adults who meet eligibility criteria.
It works by mimicking a naturally occurring hormone called GLP-1, helping to:
Clinical studies have shown that many patients achieve significant weight loss when Wegovy is combined with a reduced-calorie diet and increased physical activity.
Wegovy may be suitable for adults who:
Our clinicians will assess your medical history and suitability during your consultation.
Wegovy has demonstrated impressive weight loss results in clinical studies.
Simple once-weekly injection schedule.
Many patients experience reduced hunger and fewer food cravings.
Feeling fuller for longer can help reduce calorie intake naturally.
Can support sustained weight loss when combined with healthy lifestyle habits.
In addition to supporting weight loss, Wegovy has also been approved for reducing the risk of major cardiovascular events in certain adults with established cardiovascular disease and overweight or obesity. Suitability for treatment will be assessed during your consultation.
Your dose will be tailored during your consultation. All prices are per month of treatment
Weight loss varies between individuals. Clinical studies have shown that people using Wegovy can lose an average of up to 20.7% of their body weight when treated with the higher 7.2mg dose alongside diet and lifestyle changes.
Wegovy is administered once weekly.
Yes. Wegovy is a prescription-only medicine and requires a clinical assessment.
Common side effects may include nausea, vomiting, diarrhoea, constipation and stomach discomfort. Most side effects improve as treatment continues.
Many patients begin noticing appetite changes within the first few weeks. Weight loss results vary between individuals.
In some cases, patients may be able to switch treatments. Our clinicians can discuss suitable options during your consultation.
Yes. Wegovy is now available in both injection and tablet formulations. The Wegovy pill contains semaglutide (same as the injection) and is going to be available in July 2026.
Both Wegovy and Mounjaro are highly effective weight loss treatments. Clinical studies have shown average weight loss of up to 20.7% with higher-dose Wegovy and up to 22.5% with Mounjaro. The most suitable treatment depends on your medical history, weight loss goals and clinical assessment.
We also offer Mounjaro weight loss injections for suitable patients